NASDAQ: NEOGNeogen Corp Stock Ownership - Who owns Neogen?
Insider buying vs selling
Have Neogen Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Douglas Edward Jones | Chief Operating Officer | 2024-04-25 | 845 | $11.96 | $10.11kBuy |
| John Edward Adent | CEO | 2024-04-25 | 615 | $11.96 | $7.36kSell |
| John Edward Adent | CEO | 2024-04-25 | 2,113 | $11.96 | $25.27kBuy |
| Amy M. Rocklin | Chief Legal Officer | 2024-04-25 | 563 | $11.96 | $6.73kBuy |
| Douglas Edward Jones | Chief Operating Officer | 2024-04-25 | 291 | $11.96 | $3.48kSell |
| John Edward Adent | CEO | 2024-04-23 | 17,477 | $12.09 | $211.30kBuy |
| Douglas Edward Jones | Chief Operating Officer | 2024-04-17 | 10,000 | $12.36 | $123.59kBuy |
| James C. Borel | Director | 2024-04-11 | 7,500 | $13.07 | $97.99kBuy |
| John Edward Adent | CEO | 2024-04-10 | 23,000 | $12.36 | $284.19kBuy |
| David H. Naemura | CFO | 2024-04-10 | 12,500 | $12.51 | $156.33kBuy |
NEOG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NEOG insiders and whales buy or sell their stock.
NEOG Shareholders
What type of owners hold Neogen Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 11.47% | 24,852,060 | $297.23M | Institution |
| Vanguard Group Inc | 9.02% | 19,546,737 | $233.78M | Institution |
| Norges Bank | 8.40% | 18,189,674 | $217.55M | Institution |
| Wasatch Advisors LP | 4.31% | 9,345,783 | $111.78M | Institution |
| Select Equity Group LP | 3.86% | 8,365,600 | $100.05M | Institution |
| Baillie Gifford Co | 3.83% | 8,286,714 | $99.11M | Institution |
| William Blair Investment Management LLC | 3.48% | 7,536,169 | $90.13M | Institution |
| State Street Corp | 3.44% | 7,460,004 | $89.22M | Institution |
| Conestoga Capital Advisors LLC | 3.15% | 6,817,600 | $81.54M | Institution |
| Bamco Inc | 3.06% | 6,624,299 | $79.23M | Institution |
NEOG vs Diagnostic & Research Stocks
Neogen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.